Перегляд вихідного коду сторінки What Venetoclax Professionals Is Likely To Coach You On

Measles has re-emerged in the EU recently as the result of sub-optimal immunization levels that have increased susceptible populations [1, 2]. More than half these cases have been reported in France: nearly 15?000 cases in 2011, including 714 of severe measles-related pneumonia, 16 of acute measles encephalitis and [http://www.selleckchem.com/products/abt-199.html learn more] six measles-related deaths, compared with 30?567 cases in Europe that year [1-3]. Together with France, four countries��Italy, Romania, Spain and Germany��accounted for >90% of all measles cases reported in 2011 [1, 2]. The measles outbreak in France began in 2008. The number of reported cases has decreased sharply since May 2011 [3]. The proportion of cases ��20?years old reached 38% during the first half of 2010 [3, 4]. Nonetheless, France has promoted measles vaccination for years, with national and regional campaigns in place since 1990 [3, 4]. A trivalent MMR vaccine has been recommended since 1983 and available free of charge since 1999 [3, 4]. Health authorities launched a national plan to eliminate measles in 2005 and strengthened it in 2009 [3-5]. The European Immunization Weeks in 2009, 2010 and 2011 provided an opportunity to reinforce [http://www.selleckchem.com/products/MDV3100.html Enzalutamide in vitro] communication, focusing especially on vaccination recommendations [4]. A communication campaign took place in France from September 2011 to February 2012. The first dose (MMR1) is currently recommended at the age of 12?months and the second dose (MMR2) during the second year of life [3]. Since 1997, a catch-up measles vaccination programme with two doses has been recommended for children born in 1992 or later; in 2011, it was extended to everyone born in or after 1980 [3]. Children [http://en.wikipedia.org/wiki/Histone_demethylase Histone demethylase] 5]. Measles incidence and MMR coverage rates vary regionally throughout France [3]. The southeastern region is characterized by vaccination coverage below the national average: 86% for MMR1 and 40% for MMR2 in 2003�C04 for children aged 15?years, compared with 94% and 66%, respectively, nationwide [6]. Accordingly, although this region contained only 7.6% of the total French population in 2009, it accounted for 15.6% of all measles cases reported in France in 2011 [3]. Organizational problems, combined with social, psychological and behavioural determinants, are the leading causes of sub-optimal immunization levels [1].